Joint Venture (Invizyne Technologies / Neuractas Therapeutics) Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Joint Venture

  • Financing Rounds
  • 1

Joint Venture (Invizyne Technologies / Neuractas Therapeutics) General Information

Description

Distributor of pharmaceutical products based in Monrovia, California. The company offers the sale and licensing of healthcare products.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Monrovia, CA 91016
  • United States
Primary Industry
Drug Delivery
Other Industries
Other Pharmaceuticals and Biotechnology
Distributors/Wholesale
Corporate Office
  • Monrovia, CA 91016
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Joint Venture (Invizyne Technologies / Neuractas Therapeutics) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Joint Venture (Invizyne Technologies / Neuractas Therapeutics)‘s full profile, request access.

Request a free trial

Joint Venture (Invizyne Technologies / Neuractas Therapeutics) Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Joint Venture (Invizyne Technologies / Neuractas Therapeutics)‘s full profile, request access.

Request a free trial

Joint Venture (Invizyne Technologies / Neuractas Therapeutics) FAQs

  • When was Joint Venture (Invizyne Technologies / Neuractas Therapeutics) founded?

    Joint Venture (Invizyne Technologies / Neuractas Therapeutics) was founded in 2022.

  • Where is Joint Venture (Invizyne Technologies / Neuractas Therapeutics) headquartered?

    Joint Venture (Invizyne Technologies / Neuractas Therapeutics) is headquartered in Monrovia, CA.

  • What industry is Joint Venture (Invizyne Technologies / Neuractas Therapeutics) in?

    Joint Venture (Invizyne Technologies / Neuractas Therapeutics)’s primary industry is Drug Delivery.

  • Is Joint Venture (Invizyne Technologies / Neuractas Therapeutics) a private or public company?

    Joint Venture (Invizyne Technologies / Neuractas Therapeutics) is a Private company.

  • What is Joint Venture (Invizyne Technologies / Neuractas Therapeutics)’s current revenue?

    The current revenue for Joint Venture (Invizyne Technologies / Neuractas Therapeutics) is .

  • Who are Joint Venture (Invizyne Technologies / Neuractas Therapeutics)’s investors?

    eXoZymes and Neuractas Therapeutics have invested in Joint Venture (Invizyne Technologies / Neuractas Therapeutics).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process